Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
ThermoMind logo — Next Generation Multimodal Screening Modality

ThermoMind

Next Generation Multimodal Screening Modality

Founded 2022 Israel Israel 5 employees Grant Total: $11.43M Health Care, Medical Devices

General Information

Company Name ThermoMind
Founded Year 2022
Location Israel Israel +2
Founders / Decision Makers
Team member
Employees 5
Industries Health Care, Medical Devices
Funding Stage Grant
Social

Get notified when ThermoMind moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About ThermoMind

ThermoMind is a pioneering technology in the health care industry, founded in 2022 and based in Israel. The company's slogan, "Next Generation Multimodal Screening Modality," captures its core mission. ThermoMind's advanced approach combines Dynamic Multimodal Imaging and artificial intelligence to immediately detect and track biomarkers related to metabolic abnormalities caused by cancer cells. This innovative technology has recently attracted substantial investment, with a €11.43M grant investment received on 05 August 2022. The latest funding round signifies a strong endorsement of ThermoMind's potential to revolutionize cancer screening and diagnosis.

Taxonomy: Medical Device, Diagnostic Device, Breast Cancer Detection, Infrared Imaging, Cancer Biomarkers, Early Cancer Detection, Women's Health, Telemedicine

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• - 05 Aug 2022

ThermoMind Alternatives & Competitors

ThermoMind vs
Dermavision Solutions
Dermavision Solutions Spain

Creating a novel medical device to enhance melanoma early detection.

9 employees
AI, Medical Devices
ThermoMind vs
DeepX Health
DeepX Health United States

We improve patient care and save lives.

11 employees
Health Care, Health and Wellness
ThermoMind vs
Harae Dx Corp.
Harae Dx Corp. United States

Harae Dx is developing the worlds first low-cost portable Automated cancer detection system

Series A
6 employees
Biotechnology, Health Care

FAQ About ThermoMind

Next Generation Multimodal Screening Modality
ThermoMind was founded in 2022.
ThermoMind is headquartered in Israel.
ThermoMind operates in the following industries: Health Care, Medical Devices.
ThermoMind has approximately 5 employees.
ThermoMind has completed 1 funding round, raising a total of $11.43M. The latest funding stage is Grant.
Top alternatives and competitors to ThermoMind include Dermavision Solutions, DeepX Health , Harae Dx Corp., MiWEndo Solutions, Cyrcadia Health. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ThermoMind and Dermavision Solutions are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors ThermoMind and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy